|  Help  |  About  |  Contact Us

Publication : Aberrant cortical development is driven by impaired cell cycle and translational control in a <i>DDX3X</i> syndrome model.

First Author  Hoye ML Year  2022
Journal  Elife Volume  11
PubMed ID  35762573 Mgi Jnum  J:326220
Mgi Id  MGI:7295026 Doi  10.7554/eLife.78203
Citation  Hoye ML, et al. (2022) Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model. Elife 11:e78203
abstractText  Mutations in the RNA helicase, DDX3X, are a leading cause of Intellectual Disability and present as DDX3X syndrome, a neurodevelopmental disorder associated with cortical malformations and autism. Yet, the cellular and molecular mechanisms by which DDX3X controls cortical development are largely unknown. Here, using a mouse model of Ddx3x loss-of-function we demonstrate that DDX3X directs translational and cell cycle control of neural progenitors, which underlies precise corticogenesis. First, we show brain development is sensitive to Ddx3x dosage; complete Ddx3x loss from neural progenitors causes microcephaly in females, whereas hemizygous males and heterozygous females show reduced neurogenesis without marked microcephaly. In addition, Ddx3x loss is sexually dimorphic, as its paralog, Ddx3y, compensates for Ddx3x in the developing male neocortex. Using live imaging of progenitors, we show that DDX3X promotes neuronal generation by regulating both cell cycle duration and neurogenic divisions. Finally, we use ribosome profiling in vivo to discover the repertoire of translated transcripts in neural progenitors, including those which are DDX3X-dependent and essential for neurogenesis. Our study reveals invaluable new insights into the etiology of DDX3X syndrome, implicating dysregulated progenitor cell cycle dynamics and translation as pathogenic mechanisms.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

28 Bio Entities

Trail: Publication

0 Expression